קלטרה תמיסה
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - תמיסה (פומי) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir
קלטרה תמיסה
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - תמיסה (פומי) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir
רזולסטה
j-c health care ltd - cobicistate; darunavir as ethanolate - טבליות מצופות פילם - cobicistate 150 mg; darunavir as ethanolate 800 mg - darunavir
קלטרה 200 מג50 מג טבליות
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - טבליות מצופות פילם - ritonavir 50 mg; lopinavir 200 mg - lopinavir - lopinavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
קלטרה 200 מג50 מג טבליות
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - טבליות מצופות פילם - ritonavir 50 mg; lopinavir 200 mg - lopinavir - lopinavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
נורויר כמוסות רכות 100 מ"ג
abbvie biopharmaceuticals ltd, israel - ritonavir 100 mg - capsules - ritonavir - is indicated alone or in combination with other antiretroviral agents for the treatment of patients with hiv infection when therapy is warranted based on clinical and/or immunological evidence of disease progression.
נורויר כמוסות רכות 100 מ"ג
abbvie biopharmaceuticals ltd, israel - ritonavir 100 mg - capsules - ritonavir - is indicated alone or in combination with other antiretroviral agents for the treatment of patients with hiv infection when therapy is warranted based on clinical and/or immunological evidence of disease progression.
טייקרב
novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.
דקסילנט 30 מג
takeda israel ltd - dexlansoprazole - קפסולות בשחרור מושהה - dexlansoprazole 30 mg - dexlansoprazole
דקסילנט 60 מג
takeda israel ltd - dexlansoprazole - קפסולות בשחרור מושהה - dexlansoprazole 60 mg - dexlansoprazole